Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Eckmann

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Arzneimittel-Forschung|February 1, 1970
[Clinical studies with oxypertine in chronically psychotic patients]F Eckmann, L Badalik
Fortschritte Der Medizin|August 26, 1982
[Controlled double-blind study for the determination of the effect of Tebonin forte in patients with cerebrovascular insufficiency]F Eckmann, H Schlag
Arzneimittel-Forschung|January 1, 1977
[Studies on cardio-circulatory effects of carpipramine. Results of a double-blind study (author's transl)]F Eckmann, J Sommer, W Trummer
Der Nervenarzt|September 1, 1981
[Psychotropic drugs and cardiac risk factors (author's transl)]H Schwalb, F Eckmann, H Brüninghaus
Pharmakopsychiatrie, Neuro-Psychopharmakologie|March 1, 1975
[Psychotropic agents and pathological ECG changes (author's transl)]F Eckmann, H Schwalb, R Hanika
Arzneimittel-Forschung|August 1, 1974
[Differential effects of neuroleptic drugs in chronic schizophrenics. A configuration analytical evaluation]F Eckmann, A Gebert, G A Lienert
Pharmakopsychiatrie, Neuro-Psychopharmakologie|December 1, 1975
[Are neuroleptic drugs anticarcinogenic? (author's transl)]F Eckmann, H Immich, H R Scheurlen
European Archives of Psychiatry and Neurological Sciences|January 1, 1985
Self-rating data as a selecting factor in clinical trials of psychotropic drugsU Baumann, F Eckmann, R D Stieglitz
International Pharmacopsychiatry|January 1, 1978
[Incidence of tumors during neuroleptic treatment]F Eckmann, H Immich, H R Scheurlen
Fortschritte Der Neurologie, Psychiatrie, Und Ihrer Grenzgebiete|September 1, 1978
[ECG changes in psychiatric patients under long-term therapy with psychopharmaca (author's transl)]H Schwalb, F Eckmann, W van Eimeren
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Arzneimittel-Forschung|February 1, 1970
[Clinical studies with oxypertine in chronically psychotic patients]F Eckmann, L Badalik
Fortschritte Der Medizin|August 26, 1982
[Controlled double-blind study for the determination of the effect of Tebonin forte in patients with cerebrovascular insufficiency]F Eckmann, H Schlag
Arzneimittel-Forschung|January 1, 1977
[Studies on cardio-circulatory effects of carpipramine. Results of a double-blind study (author's transl)]F Eckmann, J Sommer, W Trummer
Der Nervenarzt|September 1, 1981
[Psychotropic drugs and cardiac risk factors (author's transl)]H Schwalb, F Eckmann, H Brüninghaus
Pharmakopsychiatrie, Neuro-Psychopharmakologie|March 1, 1975
[Psychotropic agents and pathological ECG changes (author's transl)]F Eckmann, H Schwalb, R Hanika
Arzneimittel-Forschung|August 1, 1974
[Differential effects of neuroleptic drugs in chronic schizophrenics. A configuration analytical evaluation]F Eckmann, A Gebert, G A Lienert
Pharmakopsychiatrie, Neuro-Psychopharmakologie|December 1, 1975
[Are neuroleptic drugs anticarcinogenic? (author's transl)]F Eckmann, H Immich, H R Scheurlen
European Archives of Psychiatry and Neurological Sciences|January 1, 1985
Self-rating data as a selecting factor in clinical trials of psychotropic drugsU Baumann, F Eckmann, R D Stieglitz
International Pharmacopsychiatry|January 1, 1978
[Incidence of tumors during neuroleptic treatment]F Eckmann, H Immich, H R Scheurlen
Fortschritte Der Neurologie, Psychiatrie, Und Ihrer Grenzgebiete|September 1, 1978
[ECG changes in psychiatric patients under long-term therapy with psychopharmaca (author's transl)]H Schwalb, F Eckmann, W van Eimeren
Pageof 4